Ashland Inc. which can be found using ticker (ASH) now have 11 analysts in total covering the stock. The consensus rating is pointing to ‘Buy’. The target price High/Low ranges between 144 and 105 calculating the average target price we see $126.91. Given that the stocks previous close was at $102.26 this now indicates there is a potential upside of 24.1%. The 50 day MA is $102.58 and the 200 day moving average is $103.41. The total market capitalization for the company now stands at $5,574m. Find out more information at: https://www.ashland.com
The potential market cap would be $6,918m based on the market consensus.
Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
The company has a dividend yield of 1.3% with the ex dividend date set at 28-2-2023 (DMY).
Other points of data to note are a P/E ratio of 30.12, revenue per share of 44.31 and a 2.96% return on assets.
